In assessing prognostic value, it was observed that high expression of ARPC1A was positively associated with poor prognosis in LGG, LIHC, GBM, LUAD, UVM, ACC, KIRC, STAD, and MESO. This evidence concerns the gene ARPC1A and adrenal cortex carcinoma.